No Record Found
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
NAV Date | : | 24-Apr-2024 |
NAV [Rs.] | : | 20.86 |
Buy/Resale Price [Rs.] | : | 0 |
Sell/Repurchase Price [Rs.] | : | 0 |
Entry Load % | : | Nil |
Exit Load % | : | For redemption / switch-out of units on or before 90 days from the date of allotment: 0.5% of applicable NAV. For redemption / switch-out of units after 90 days from the date of allotment: : Nil h |
1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
---|---|---|---|---|---|---|---|---|
Scheme Returns | 0.05 | -0.24 | 3.68 | 27.04 | 55.06 | 15.74 | 23.69 | |
Category Avg | -0.03 | 1.34 | 4.89 | 26.39 | 51.42 | 16.00 | 23.17 | 19.38 |
Category Best | 2.01 | 7.13 | 7.14 | 34.88 | 58.23 | 19.05 | 27.20 | 39.93 |
Category Worst | 0.05 | -0.24 | 3.68 | 27.04 | 55.06 | 15.74 | 23.69 |
Dividends | Bonus | |
---|---|---|
Ratio | 11.26 | 0.00 |
Date | 20-09-2023 | 20-09-2023 |
Min. Investment(Rs.) | : | 1000 |
Increm.Investment(Rs.) | : | 1000 |
Calculate the worth of your wealth at retirement
In | |
Name of the Company | No of shares |
No Record Found
Out | |
Name of the Company | No of shares |
No Record Found
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) | ||||
---|---|---|---|---|---|---|---|---|---|
Equity & Equity related Investments | |||||||||
Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 15.74 | 6,79,456.00 | 110.11 | ||||
Equity | Cipla | Pharmaceuticals & Biotechnology | 8.31 | 3,88,342.00 | 58.13 | ||||
Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 7.24 | 1,94,696.00 | 50.63 | ||||
Equity | Apollo Hospitals | Healthcare Services | 6.72 | 73,936.00 | 47.00 | ||||
Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 4.46 | 3,09,792.00 | 31.21 | ||||
Equity | Fortis Health. | Healthcare Services | 4.37 | 7,27,564.00 | 30.57 | ||||
Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 4.16 | 1,30,419.00 | 29.09 | ||||
Equity | Lupin | Pharmaceuticals & Biotechnology | 3.80 | 1,64,214.00 | 26.55 | ||||
Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 3.59 | 1,36,128.00 | 25.12 | ||||
Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.52 | 49,770.00 | 24.60 | ||||
Equity | Alembic Pharma | Pharmaceuticals & Biotechnology | 3.38 | 2,40,291.00 | 23.66 | ||||
Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.10 | 7,994.00 | 21.68 | ||||
Equity | J B Chem & Pharm | Pharmaceuticals & Biotechnology | 2.90 | 1,22,938.00 | 20.29 | ||||
Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 2.80 | 31,795.00 | 19.58 | ||||
Equity | Sanofi India | Pharmaceuticals & Biotechnology | 2.66 | 22,949.00 | 18.62 | ||||
Equity | Strides Pharma | Pharmaceuticals & Biotechnology | 2.28 | 2,02,997.00 | 15.93 | ||||
Equity | Jupiter Life Lin | Healthcare Services | 2.25 | 1,31,408.00 | 15.72 | ||||
Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.12 | 1,36,254.00 | 14.83 | ||||
Equity | Vijaya Diagnost. | Healthcare Services | 2.01 | 2,20,987.00 | 14.07 | ||||
Equity | Star Health Insu | Insurance | 1.90 | 2,44,444.00 | 13.28 | ||||
Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 1.47 | 44,835.00 | 10.32 | ||||
Equity | Medi Assist Ser. | Insurance | 1.04 | 1,43,535.00 | 7.26 | ||||
Equity | Granules India | Pharmaceuticals & Biotechnology | 0.91 | 1,47,600.00 | 6.35 | ||||
Equity | ERIS Lifescience | Pharmaceuticals & Biotechnology | 0.80 | 66,534.00 | 5.61 | ||||
Equity | Biocon | Pharmaceuticals & Biotechnology | 0.56 | 1,48,818.00 | 3.93 | ||||
Equity | Medplus Health | Retailing | 0.56 | 56,620.00 | 3.89 | ||||
Equity | Vinati Organics | Chemicals & Petrochemicals | 0.40 | 18,952.00 | 2.79 | ||||
Cash & Cash Equivalent | |||||||||
Reverse Repo | C C I | -/- | 6.68 | 0.00 | 46.72 | ||||
Net CA & Others | Net CA & Others | -/- | 0.29 | 0.00 | 2.00 |
Fund House | : Aditya Birla Sun Life AMC Ltd |
Incorporation Date | : 05-Sep-1994 |
Total Assets Managed (Cr.) | : 3,32,579.31 |
Trustee/s | : Mr. karim Gilani |
Chairman | : N/A |
CEO / MD | : Mr.A.Balasubramanian |
CIO | : N/A |
President | : N/A |
Director/s | : Mr.Amrit Kanwal |
Compliance Officer/s | : N/A |
Investor Service Officer/s | : Ms.Keerti Gupta |
Fund Manager/s | : Dhaval Shah |
Auditors | : M/s Deloitte Haskins & Se |
Registered Office | : One World Centre,Tower 1,17th Flr, Jupiter Mills,senapati Bapat Marg,Elphinstone Road, Mumbai 400013 |
Contact Nos | : 43568000 |
Fax | : 43568110/8111 |
: care.mutualfunds@adityabirlacapital.com | |
Website | : https://mutualfund.adityabirlacapital.com |
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.